Asthma
COPD
Pulmonary
Search
Article
Blog
Company
Podcast
Product
Video
Whitepaper
Enter search phrase
Search
Pulmonary
CHEST launches pulmonary program for advanced practitioners
The inaugural education and certification program will fill a demand for additional pulmonary medicine support.
November 13, 2026
COPD
Phase 3 trial initiated for investigational oral COPD therapy
Verducatib is a treatment option targeting dipeptidyl peptidase 1 in adult COPD patients.
November 12, 2026
COPD
Merck begins phase 3 study for ensifentrine COPD treatment
Ensifentrine is the first and only novel inhaled mechanism for the maintenance treatment of COPD in more than 20 years to combine bronchodilation and non-corticosteroid anti-inflammatory effects.
November 12, 2026
Asthma
Three new genes linked to allergic asthma
Researchers named four variants in the development of adult- and childhood-onset allergic asthma.
November 11, 2026
Asthma
Asthma worsens alongside mental health conditions
Researchers advocate for routine mental health screenings as part of standard asthma care.
November 11, 2026
Pulmonary
Long-term impact of pediatric TB patients
More than half of children have abnormal lung function one year after treatment for tuberculosis.
November 5, 2026
Asthma
Primary care initiative tackles asthma rescue inhaler overuse
Interventions like patient education, asthma review reminders and clinician awareness reduced overreliance by nearly two-thirds.
November 5, 2026
Asthma
The potential of nebulized hypertonic saline for severe asthma
Observational study suggests significant reductions in asthma flareups and hospital admissions.
November 5, 2026
Pulmonary
Advancements in RNA extraction from precision-cut lung slices
Yale researchers have developed new approaches that better preserve lung cell types and structures.
November 5, 2026
COPD
FDA grants clearance for treprostinil soft mist inhaler clinical trial
The new application could be the first approved treatment for pulmonary hypertension associated with COPD.
November 4, 2026
COPD
COPD treatment falls short in phase 2 proof-of-concept trial
Fexlamose did not demonstrate improvements in FEV1, FVC or other spirometric measures in patients with COPD.
November 4, 2026
COPD
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The treatment was particularly effective in high-dose courses among those with type 2 inflammation.
October 29, 2026
COPD
Study reveals BMI's limitations in predicting COPD risk
Research suggests a more disease-specific approach to obesity assessment and weight management is warranted.
October 29, 2026
Pulmonary
Hidden immune cell unlocks novel SCLC treatment approach
In laboratory experiments, the identified immune cells found and killed small cell lung cancer.
October 29, 2026
Asthma
Allergy treatment shows promise in changing the course of asthma
Allergen immunotherapy addresses the root causes of allergic disease versus controlling symptoms alone.
October 29, 2026
Asthma
The overlooked burden of comorbidities in severe asthma care
From obesity to gastroesophageal reflux disease, added health conditions are
linked to poor asthma control and reduced quality of life.
October 29, 2026
Pulmonary
Investigational treatment begins for heart-related PH
Pulmonary artery denervation was performed on the first two U.S. patients enrolled in the PULSE-LHD clinical trial.
October 28, 2026
Pulmonary
Identifying lung cancer a decade early
Blood-based approach discovered at the University of Hawai’i could be used in lung cancer assessments to predict risk prior to cancer formation.
October 22, 2026
Next Page